A subsidiary of Chinese life science company BGI has received RMB2 billion (US$320 million) investment from several unnamed Chinese institutional investors, according to Chinese media reports.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?